Secukinumab
Catalogue number:
HY-P9927-5mg
Supplier:
Size:
5 mg
Product is available in:
Applications:
COVID-19-immunoregulation
Target:
Interleukin Related
Alternative Names:
AIN457
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL)-17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing spondylitis and psoriatic arthritis[1][2].